Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus

SM Alobaid, RM Alshahrani, AS Alonazi… - Pharmaceuticals, 2024 - mdpi.com
One of the possible candidates for the treatment of diabetic cardiomyopathy is liraglutide, a
glucagon-like peptide-1 receptor (GLP1R) agonist. In this study, the impacts of liraglutide on …

Differentiating Stages of Bipolar and Unipolar Depression—The Possible Role of sICAM-1 and sVCAM-1

M Pantovic-Stefanovic, N Petronijevic, B Dunjic-Kostic… - Cells, 2024 - pmc.ncbi.nlm.nih.gov
Increased immune–inflammatory activation has been repeatedly linked to etiopathogenesis
and the progression of both major depressive disorder (MDD) and bipolar depression (BD) …

Amitriptyline Decreases Mouse Lung Endothelial Cell Inflammatory Responses to Packed Red Blood Cell Microparticles

L Wattley, R Chae, C Nguyen, R Schuster… - Journal of Surgical …, 2024 - Elsevier
Introduction Large-volume packed red blood cell (pRBC) transfusion is associated with lung
injury and worsened outcomes. Amitriptyline reduces lung injury and inflammation in a …